United States · FDA National Drug Code directory
CLORAZEPATE DIPOTASSIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13107-284_69451c35-dd9a-4690-8d5e-4dcfa8837620
- Product NDC
- 13107-284
- Form
- TABLET
- Composition / generic term
- CLORAZEPATE DIPOTASSIUM
- Labeler
- Aurolife Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230923
- Source listing expiry
- 20261231
Source-listed ingredients
- CLORAZEPATE DIPOTASSIUM — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (13107-284-01) · 13107-284-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →